Mark Dowar

849 total citations
12 papers, 460 citations indexed

About

Mark Dowar is a scholar working on Cancer Research, Oncology and Hematology. According to data from OpenAlex, Mark Dowar has authored 12 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 4 papers in Oncology and 3 papers in Hematology. Recurrent topics in Mark Dowar's work include Cancer Genomics and Diagnostics (7 papers), Multiple Myeloma Research and Treatments (3 papers) and Thyroid Cancer Diagnosis and Treatment (3 papers). Mark Dowar is often cited by papers focused on Cancer Genomics and Diagnostics (7 papers), Multiple Myeloma Research and Treatments (3 papers) and Thyroid Cancer Diagnosis and Treatment (3 papers). Mark Dowar collaborates with scholars based in Canada and United States. Mark Dowar's co-authors include Trevor J. Pugh, Tiantian Li, Amit M. Oza, Steven Orlov, Paul G. Walfish, Jeremy L. Freeman, S.Y. Cindy Yang, Jonathan Yip, Arnavaz Danesh and Blaise Clarke and has published in prestigious journals such as Nature Communications, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Mark Dowar

12 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Dowar Canada	9	214	146	144	104	83	12	460
Markus Mayrhofer Sweden	12	153 0.7×	181 1.2×	101 0.7×	108 1.0×	135 1.6×	21	506
Sabrina Coluzzi Italy	7	275 1.3×	267 1.8×	111 0.8×	144 1.4×	47 0.6×	7	584
M.F. Fey Switzerland	9	139 0.6×	40 0.3×	137 1.0×	120 1.2×	45 0.5×	15	357
Elpida Charalambous Greece	11	189 0.9×	79 0.5×	178 1.2×	47 0.5×	42 0.5×	18	343
Justine N. McCutcheon United States	11	204 1.0×	99 0.7×	304 2.1×	110 1.1×	42 0.5×	16	680
Benjamin J. Gigliotti United States	7	106 0.5×	28 0.2×	188 1.3×	158 1.5×	28 0.3×	18	392
Antonella Marzullo Italy	9	92 0.4×	64 0.4×	89 0.6×	202 1.9×	30 0.4×	22	376
Ines Figueiredo United Kingdom	11	185 0.9×	232 1.6×	237 1.6×	90 0.9×	40 0.5×	26	576
A. Valent France	10	101 0.5×	89 0.6×	155 1.1×	18 0.2×	24 0.3×	18	318
André Uchimura Bastos Brazil	12	236 1.1×	135 0.9×	105 0.7×	221 2.1×	86 1.0×	17	494

Countries citing papers authored by Mark Dowar

Since Specialization

Citations

This map shows the geographic impact of Mark Dowar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Dowar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Dowar more than expected).

Fields of papers citing papers by Mark Dowar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Dowar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Dowar. The network helps show where Mark Dowar may publish in the future.

Co-authorship network of co-authors of Mark Dowar

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Dowar. A scholar is included among the top collaborators of Mark Dowar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Dowar. Mark Dowar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Yang, S.Y. Cindy, Stéphanie Lheureux, Katherine Karakasis, et al.. (2018). Landscape of genomic alterations in high-grade serous ovarian cancer from exceptional long- and short-term survivors. Genome Medicine. 10(1). 81–81. 66 indexed citations

Mulder, David T., Etienne Mahé, Mark Dowar, et al.. (2018). CapTCR-seq: hybrid capture for T-cell receptor repertoire profiling. Blood Advances. 2(23). 3506–3514. 10 indexed citations

Kis, Olena, Rayan Kaedbey, Signy Chow, et al.. (2017). Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates. Nature Communications. 8(1). 15086–15086. 100 indexed citations

Kis, Olena, Signy Chow, Rayan Kaedbey, et al.. (2017). Targeted Sequencing of Circulating Cell-free DNA in Multiple Myeloma Allows Analysis of Somatic Mutations, Copy Number Aberrations, and Translocations. Clinical Lymphoma Myeloma & Leukemia. 17(1). e93–e94. 1 indexed citations

Lheureux, Stéphanie, Jeff Bruce, Julia V. Burnier, et al.. (2017). Somatic BRCA1/2 Recovery as a Resistance Mechanism After Exceptional Response to Poly (ADP-ribose) Polymerase Inhibition. Journal of Clinical Oncology. 35(11). 1240–1249. 73 indexed citations

Bailey, Swneke D., Kinjal Desai, Ken J. Kron, et al.. (2016). Noncoding somatic and inherited single-nucleotide variants converge to promote ESR1 expression in breast cancer. Nature Genetics. 48(10). 1260–1266. 57 indexed citations

Bavi, Prashant, Dianne Chadwick, Arnavaz Danesh, et al.. (2016). Abstract 167: Inferring subclonal relationships between multiple metastases from rapid autopsy of a single melanoma patient. Cancer Research. 76(14_Supplement). 167–167. 1 indexed citations

Kaedbey, Rayan, Olena Kis, Arnavaz Danesh, et al.. (2015). Noninvasive diagnosis of actionable mutations by deep sequencing of circulating cell free DNA (cfDNA) in multiple myeloma (MM). Clinical Lymphoma Myeloma & Leukemia. 15. e45–e46. 3 indexed citations

Özçelik, Hilmi, Xuejiang Shi, Martin C. Chang, et al.. (2012). Long-Range PCR and Next-Generation Sequencing of BRCA1 and BRCA2 in Breast Cancer. Journal of Molecular Diagnostics. 14(5). 467–475. 45 indexed citations

10.

Vaisman, A, Steven Orlov, Jonathan Yip, et al.. (2010). Application of post‐surgical stimulated thyroglobulin for radioiodine remnant ablation selection in low‐risk papillary thyroid carcinoma. Head & Neck. 32(6). 689–698. 65 indexed citations

11.

Orlov, Steven, David Orlov, Mark Dowar, et al.. (2009). Influence of age and primary tumor size on the risk for residual/recurrent well‐differentiated thyroid carcinoma. Head & Neck. 31(6). 782–788. 26 indexed citations

12.

Sawka, Anna M., Steven Orlov, Mark Dowar, et al.. (2007). Prognostic value of postsurgical stimulated thyroglobulin levels after initial radioactive iodine therapy in well‐differentiated thyroid carcinoma. Head & Neck. 30(6). 693–700. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact